AcquisitionOther
Lomond Therapeutics Holdings, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Lomond Therapeutics Holdings, Inc. -> target · $0.0001
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years then ended, in conformity with
Open source record (SEC) ↗